SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-007064
Filing Date
2024-01-24
Accepted
2024-01-24 17:20:08
Documents
1
Period of Report
2024-01-24

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 9535
  Complete submission text file 0000950170-24-007064.txt   11117
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Issuer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ, BLD. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address
Beck Joanne T. (Reporting) CIK: 0001768045 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38722 | Film No.: 24557698